Abstract:Two different mechanisms are considered to be the primary cause of aging. Cumulative DNA damage caused by reactive oxygen species (ROS), the by-products of oxidative phosphorylation, is one of these mechanisms (ROS concept). Constitutive stimulation of mitogen- and nutrient-sensing mTOR/S6 signaling is the second mechanism (TOR concept). The flow- and laser scanning- cytometric methods were developed to measure the level of the constitutive DNA damage/ROS- as well as of mTOR/S6- signaling in individual cells. Specifically, persistent activation of ATM and expression of γH2AX in untreated cells appears to report constitutive DNA damage induced by endogenous ROS. The level of phosphorylation of Ser235/236-ribosomal protein (RP), of Ser2448-mTOR and of Ser65-4EBP1, informs on constitutive signaling along the mTOR/S6 pathway. Potential gero-suppressive agents rapamycin, metformin, 2-deoxyglucose, berberine, resveratrol, vitamin D3 and aspirin, all decreased the level of constitutive DNA damage signaling as seen by the reduced expression of γH2AX in proliferating A549, TK6, WI-38 cells and in mitogenically stimulated human lymphocytes. They all also decreased the level of intracellular ROS and mitochondrial trans-membrane potential ΔΨm, the marker of mitochondrial energizing as well as reduced phosphorylation of mTOR, RP-S6 and 4EBP1. The most effective was rapamycin. Although the primary target of each on these agents may be different the data are consistent with the downstream mechanism in which the decline in mTOR/S6K signaling and translation rate is coupled with a decrease in oxidative phosphorylation, (revealed by ΔΨm) that leads to reduction of ROS and oxidative DNA damage. The decreased rate of translation induced by these agents may slow down cells hypertrophy and alleviate other features of cell aging/senescence. Reduction of oxidative DNA damage may lower predisposition to neoplastic transformation which otherwise may result from errors in repair of DNA sites coding for oncogenes or tumor suppressor genes. The data suggest that combined assessment of constitutive γH2AX expression, mitochondrial activity (ROS, ΔΨm) and mTOR signaling provides an adequate gamut of cell responses to evaluate effectiveness of gero-suppressive agents.

Sch9S6K controls DNA repair and DNA damage response efficiency in aging cells

Role of C-Terminal Phosphorylation of Lamin A in DNA Damage and Cellular Senescence

Analysis of representative mutants for key DNA repair pathways on healthspan in Caenorhabditis elegans

The Mtor–s6k Pathway Links Growth Signalling to DNA Damage Response by Targeting RNF168

Dysregulation of DAF-16/FOXO3A-mediated stress responses accelerates oxidative DNA damage induced aging

DNA damage, aging, and cancer.

Telomeric epigenetic response mediated by Gadd45a regulates stem cell aging and lifespan.

Regulation of The Phosphorylation of Yeast Protein Kinase Sch9 Under Environmental Changes and During Chronological Aging

Crosstalk between the mTOR and DNA Damage Response Pathways in Fission Yeast

Sch9 regulates thelongevity and stress response by Cdc34 in yeast

DNA Damage Checkpoints in Stem Cells, Ageing and Cancer

LARP7 ameliorates cellular senescence and aging by allosterically enhancing SIRT1 deacetylase activity

G9a Coordinates with the RPA Complex to Promote DNA Damage Repair and Cell Survival

Potential anti-aging agents suppress the level of constitutive mTOR- and DNA damage- signaling

Spontaneous DNA damage to the nuclear genome promotes senescence, redox imbalance and aging

Connecting the Dots: From DNA Damage and Repair to Aging

SIRT6 in DNA repair, metabolism and ageing

Alterations in the molecular response to DNA damage during cellular aging of cultured fibroblasts: reduced AP-1 activation and collagenase gene expression

DNA damage—how and why we age?

A DNA damage checkpoint response in telomere-initiated senescence

Crosstalk between the DNA damage response and cellular senescence drives aging and age-related diseases